TET2 and acute myeloid leukemia: Mutations in TP53, TET2, and PTPN11 (protein tyrosine phosphatase, non-receptor type 11), IDH1/2, NRAS are frequent in t-AML, but FLT3 and NPM1 mutations are less frequent than de novo AML (58,61).